Products & Services
Markets
Contact Us
Become a Partner
Blog
Open Account
Sign In
Online Trading
Online Backoffice
Client Dashboard
New
Online IPO
Online Mutual Fund
E-Voting NSDL
Web Mail
Open Account
Sign In
Online Trading
Online Backoffice
Client Dashboard
New
Online IPO
Online Mutual Fund
E-Voting NSDL
Web Mail
Products & Services
Markets
Contact Us
Become a Partner
Blog
Reach out to us on
0120-4918900
Or
Get a call back
Click here
Markets
Company Info
Equity
IPO
Company Info
Derivatives
News
Announcements
Mutual Fund
Insurance
Share Price
Live Quotes
Company Profile
Board of Directors
Income Statement
Balance Sheet
Ratio Analysis
Cash Flow
Annual Results
Quarterly Results
Half Yearly Results
Shareholding
Change Name
MF Holding
Locations
Board Meetings
Corporate News
Investors Return
Ratio Analysis
Cash Flow
Annual Results
Quarterly Results
Half Yearly Results
Shareholding
Change Name
MF Holding
Locations
Board Meetings
Corporate News
Investors Return
BOARD MEETING
You can view Board Meeting of the company.
Natco Pharma Ltd.
GO
May 13
BSE
821.35
( -12.85 -1.54%)
Volume
53709
Prev. Close
834.20
Open Price
836.95
Today's Low / High
814.85
841.20
Bid. Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
52 Wk Low / High
660.05
1638.35
May 14, 10:54
NSE
832.95
(+ 7.85 0.95%)
Volume
134112
Prev. Close
825.10
Open Price
832.00
Today's Low / High
821.50
834.35
Bid Price (Qty.)
832.80 (42)
Offer Price (Qty.)
832.95 (355)
52 Wk Low / High
726.80
1639.00
ISIN No
INE987B01026
Market Cap. (
in Cr. )
14918.96
P/BV
2.55
Book Value (
)
326.79
BSE Code
524816
52 Week High/Low (
)
1639/727
FV/ML
2/1
P/E(X)
10.75
NSE Code
NATCOPHARMEQ
Book Closure
18/02/2025
EPS (
)
77.51
Div Yield (%)
1.14
Date
Purpose
28/05/2025
Audited Results
12/02/2025
Quarterly Results & Interim Dividend
12/11/2024
Quarterly Results & Interim Dividend
12/08/2024
Quarterly Results & Interim Dividend
27/05/2024
Audited Results
14/02/2024
Quarterly Results & Interim Dividend
14/11/2023
Quarterly Results & Interim Dividend
09/08/2023
Quarterly Results & Interim Dividend
29/05/2023
Audited Results
08/03/2023
Buy Back of shares